These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 35401696)
1. Comprehensive Analysis of YTHDF1 Immune Infiltrates and ceRNA in Human Esophageal Carcinoma. Liu XS; Kui XY; Gao Y; Chen XQ; Zeng J; Liu XY; Zhang Y; Zhang YH; Pei ZJ Front Genet; 2022; 13():835265. PubMed ID: 35401696 [No Abstract] [Full Text] [Related]
2. Comprehensive Analysis of GLUT1 Immune Infiltrates and ceRNA Network in Human Esophageal Carcinoma. Liu XS; Gao Y; Wu LB; Wan HB; Yan P; Jin Y; Guo SB; Wang YL; Chen XQ; Zhou LM; Yang JW; Kui XY; Liu XY; Pei ZJ Front Oncol; 2021; 11():665388. PubMed ID: 34123828 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analysis of Hexokinase 2 Immune Infiltrates and m6A Related Genes in Human Esophageal Carcinoma. Liu XS; Liu JM; Chen YJ; Li FY; Wu RM; Tan F; Zeng DB; Li W; Zhou H; Gao Y; Pei ZJ Front Cell Dev Biol; 2021; 9():715883. PubMed ID: 34708035 [No Abstract] [Full Text] [Related]
4. SLC2A1 is a Diagnostic Biomarker Involved in Immune Infiltration of Colorectal Cancer and Associated With m6A Modification and ceRNA. Liu XS; Yang JW; Zeng J; Chen XQ; Gao Y; Kui XY; Liu XY; Zhang Y; Zhang YH; Pei ZJ Front Cell Dev Biol; 2022; 10():853596. PubMed ID: 35399515 [No Abstract] [Full Text] [Related]
5. Functional enrichment analysis reveals the involvement of DARS2 in multiple biological pathways and its potential as a therapeutic target in esophageal carcinoma. Liu XS; Liu ZY; Zeng DB; Hu J; Chen XL; Gu JL; Gao Y; Pei ZJ Aging (Albany NY); 2024 Feb; 16(4):3934-3954. PubMed ID: 38382106 [TBL] [Abstract][Full Text] [Related]
6. Novel Immune-Related Ferroptosis Signature in Esophageal Cancer: An Informatics Exploration of Biological Processes Related to the TMEM161B-AS1/hsa-miR-27a-3p/GCH1 Regulatory Network. Lu M; Li J; Fan X; Xie F; Fan J; Xiong Y Front Genet; 2022; 13():829384. PubMed ID: 35281840 [No Abstract] [Full Text] [Related]
7. YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy. Hu J; Qiu D; Yu A; Hu J; Deng H; Li H; Yi Z; Chen J; Zu X Front Oncol; 2021; 11():607224. PubMed ID: 34026603 [TBL] [Abstract][Full Text] [Related]
8. FAM136A as a Diagnostic Biomarker in Esophageal Cancer: Insights into Immune Infiltration, m6A Modification, Alternative Splicing, Cuproptosis, and the ceRNA Network. Sun S; Huang C; Fan W; Wang Z; Li K; Liu X; Wang Z; Zhao T; Zhang G; Li X Adv Biol (Weinh); 2024 Nov; 8(11):e2400157. PubMed ID: 39185769 [TBL] [Abstract][Full Text] [Related]
9. Bridging Integrator 3 (BIN3) Downregulation Predicts a Poor Prognosis in Patients with Esophagus Carcinoma: A Study based on TCGA Data. Li D; Deng W; Huang G; Xiao X Comb Chem High Throughput Screen; 2023; 26(11):1974-1989. PubMed ID: 36475339 [TBL] [Abstract][Full Text] [Related]
10. Integrated analysis of competing endogenous RNA in esophageal carcinoma. Chen N; Wang Z; Yang X; Geng D; Fu J; Zhang Y J Gastrointest Oncol; 2021 Feb; 12(1):11-27. PubMed ID: 33708421 [TBL] [Abstract][Full Text] [Related]
11. Identification of lncRNA/circRNA-miRNA-mRNA ceRNA Network as Biomarkers for Hepatocellular Carcinoma. Chen S; Zhang Y; Ding X; Li W Front Genet; 2022; 13():838869. PubMed ID: 35386284 [No Abstract] [Full Text] [Related]
12. METTL3 as a novel diagnosis and treatment biomarker and its association with glycolysis, cuproptosis and ceRNA in oesophageal carcinoma. Liu XS; Zhang Y; Liu ZY; Gao Y; Yuan LL; Zeng DB; Tan F; Wan HB; Pei ZJ J Cell Mol Med; 2024 Mar; 28(6):e18195. PubMed ID: 38429907 [TBL] [Abstract][Full Text] [Related]
13. YTHDF1 regulates immune cell infiltration in gastric cancer via interaction with p53. Liao Q; Xiong J Exp Ther Med; 2024 Jun; 27(6):255. PubMed ID: 38682111 [TBL] [Abstract][Full Text] [Related]
14. LncRNA ELFN1-AS1 promotes esophageal cancer progression by up-regulating GFPT1 via sponging miR-183-3p. Zhang C; Lian H; Xie L; Yin N; Cui Y Biol Chem; 2020 Aug; 401(9):1053-1061. PubMed ID: 32229685 [TBL] [Abstract][Full Text] [Related]
15. Stemness-related gene signature for predicting therapeutic response in patients with esophageal cancer. Zhu S; Zhang G; You Q; Li F; Ding B; Liu F; Bi D; Jiang L Transl Cancer Res; 2022 Jul; 11(7):2359-2373. PubMed ID: 35966312 [TBL] [Abstract][Full Text] [Related]
16. High expression of caspase-8 as a predictive factor of poor prognosis in patients with esophageal cancer. Chai J; Lei Y; Xiang X; Ye J; Zhao H; Yi L Cancer Med; 2023 Mar; 12(6):7651-7666. PubMed ID: 36533709 [TBL] [Abstract][Full Text] [Related]
17. Identification and Validation of Chromobox Family Members as Potential Prognostic Biomarkers and Therapeutic Targets for Human Esophageal Cancer. Fang X; Wang J; Chen J; Zhuang M; Huang T; Chen Z; Huang Y; Zheng B; Wang X Front Genet; 2022; 13():851390. PubMed ID: 35464847 [No Abstract] [Full Text] [Related]
18. Differential Analysis of lncRNA, miRNA and mRNA Expression Profiles and the Prognostic Value of lncRNA in Esophageal Cancer. Liu H; Zhang Q; Lou Q; Zhang X; Cui Y; Wang P; Yang F; Wu F; Wang J; Fan T; Li S Pathol Oncol Res; 2020 Apr; 26(2):1029-1039. PubMed ID: 30972633 [TBL] [Abstract][Full Text] [Related]
19. SPC25 as a novel therapeutic and prognostic biomarker and its association with glycolysis, ferroptosis and ceRNA in lung adenocarcinoma. Liu XS; Zhang Y; Ming X; Hu J; Chen XL; Wang YL; Zhang YH; Gao Y; Pei ZJ Aging (Albany NY); 2024 Jan; 16(1):779-798. PubMed ID: 38217547 [TBL] [Abstract][Full Text] [Related]
20. Screening and verification of potential gene targets in esophageal carcinoma by bioinformatics analysis and immunohistochemistry. Wen P; Dayyani F; Tao R; Zhong X Ann Transl Med; 2022 Jan; 10(2):70. PubMed ID: 35282073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]